Approval for Stem Cell trial.

Tied to the new administration or not, many patients with severe spinal cord injuries see a massive ray of hope in the clearance of a clinical trial announced by Geron, the biotechnology company that initially applied to the Food and Drug Administration to conduct the trial last spring.

“Because the cells can turn into any type of cell in the body, the theory is they may one day be able to provide tissues to replace worn-out organs or nonfunctioning cells to treat diabetes, heart attacks and other diseases. The field is known as regenerative medicine. The Bush administration restricted federal financing for research on embryonic stem cells because creation of the cells entails the destruction of human embryos.” (even the stem cells from donated cord blood)

More here: nytimes.com/business and good luck Geron!